BG-325

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBG-325
Drug Alias NameBG-325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeishmania donovani infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversidad De Almeria
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversidad De Almeria
Active IndicationsN/A
Inactive IndicationsLeishmania donovani infection

Other Information

ATC CodeN/A
Related LinksN/A